{"id":11493,"date":"2024-03-25T09:26:07","date_gmt":"2024-03-25T08:26:07","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=11493"},"modified":"2024-03-25T15:47:02","modified_gmt":"2024-03-25T14:47:02","slug":"leo-foundation-sharpens-focus-on-the-skin-with-new-ambitions-and-awards-anniversary-prize","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2024\/03\/25\/leo-foundation-sharpens-focus-on-the-skin-with-new-ambitions-and-awards-anniversary-prize\/","title":{"rendered":"LEO Foundation sharpens focus on the skin with new ambitions, and awards anniversary prize"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n

25 March 2024<\/em><\/p>\n\n\n\n

The LEO Foundation had a successful year in terms of both philanthropy and commercial activities in 2023. The grant level increased substantially, LEO Pharma achieved a strong uplift in operating performance, and the financial investments generated solid returns. On the back of this, the Foundation is raising its ambitions toward 2030 and, at the same time, marking its 40th anniversary by awarding a prize of 5 million Danish kroner (EUR 670,500) to a researcher who has made an extraordinary contribution to skin research in Denmark.<\/strong><\/strong><\/p>\n\n\n\n

Covering two square meters and performing many functions, the skin is a vital organ of the body, providing a defense against everything from infections to sun and cold. But what happens in the skin when, for example, eczema or psoriasis occurs? Skin diseases are among the most common health problems worldwide, affecting around one in three people. We have become significantly better at treating the 3,000 or so known skin diseases, but many patients still lack effective treatments.<\/p>\n\n\n\n

The LEO Foundation is sharpening its focus on this challenge in its ambitions toward 2030. These ambitions, together with the 2023 results, are presented in the Annual Report<\/a>, published today.<\/p>\n\n\n\n

The ambitions are anchored in the Foundation\u2019s purpose \u201cLet\u2019s pave the way for curing skin disease\u201d, and in the philanthropic activities and engaged ownership of the subsidiary LEO Pharma \u2013 both with a dedicated focus on the skin and its diseases.<\/p>\n\n\n\n

\u201cThe LEO Foundation builds on a rich history, with research into and treatment of skin diseases at its heart,\u201d says CEO Peter Haahr.<\/p>\n\n\n\n

\u201cAs an enterprise foundation, we have a unique opportunity to make a difference: through our philanthropic activities, which strengthen our fundamental knowledge and understanding of the skin and its diseases through support for independent research, and via our engaged ownership of LEO Pharma, which contributes to advancing the standard of care for the benefit of people living with skin diseases.\u201d<\/p>\n\n\n\n

<\/div>\n\n\n
\n
\n
\n
\n